REGENOCELL THERAPEUTICS, INC. Proceeds from Notes Payable
REGENOCELL THERAPEUTICS, INC. reported Proceeds from Notes Payable of $165.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2012-05-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2012-05-25
- REGENOCELL THERAPEUTICS, INC. proceeds from notes payable for the quarter ending 2011-12-31 was $0.00.
- REGENOCELL THERAPEUTICS, INC. proceeds from notes payable for the quarter ending 2011-09-30 was $165.00K, a 5180.00% increase year-over-year.
- REGENOCELL THERAPEUTICS, INC. proceeds from notes payable for the quarter ending 2010-12-31 was -$3.13K.
- REGENOCELL THERAPEUTICS, INC. proceeds from notes payable for the quarter ending 2010-09-30 was $3.13K.
- REGENOCELL THERAPEUTICS, INC. proceeds from notes payable for fiscal 2011 was $165.00K, a 1550.00% increase from fiscal 2010.
- REGENOCELL THERAPEUTICS, INC. proceeds from notes payable for fiscal 2010 was $10.00K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-25 | $165.00K derived: sum of 2 quarters · filed 2012-05-25 | $165.00K 10-K · filed 2012-05-25 | |
| 2011-09-30 | $165.00K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $165.00K 10-Q · filed 2011-11-21 | ||
| 2011-06-30 | $0.00 10-Q/A · filed 2011-09-01 | |||
| 2010-12-31 | -$3.13K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-25 | $0.00 derived: sum of 2 quarters · filed 2012-05-25 | $10.00K 10-K · filed 2012-05-25 | |
| 2010-09-30 | $3.13K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-21 | $13.13K 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | $10.00K 10-Q/A · filed 2011-09-01 |